ArticleNature medicine2025
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial.
Jingjing Feng et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
41 papers cite it
this paperpooled itcites it